Tempus claims AI pathology developer Paige in $81M deal

Tempus acquired AI pathology developer Paige for $81 million, gaining access to a dataset of nearly 7 million digitized pathology slides and associated clinical data from Memorial Sloan Kettering Cancer Center. The acquisition adds Paige's machine-learning capabilities in digital pathology to Tempus's oncology-focused platform.